PharmaMar’s Lurbinectedin ATLANTIS trial design and data in small-cell lung cancer will be an oral presentation at the IASCLC´s annual meeting

February 20, 2018

Responsive image

MADRID, Feb. 20, 2018 /PRNewswire/ —

Dr Anna Farago, oncologist from the Massachusetts General Hospital and principal investigator of the phase III ATLANTIS clinical trial, will present the potential of lurbinectedin in small-cell lung cancer along with the main clinical data…

Category: Precious Metals